Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Sponsor: University Hospital, Geneva
Terminated
Lack of patient accrual
Other terminated trials from University Hospital, Geneva
A observational or N/A phase clinical study on Cirrhosis and Hepatic Encephalopathy, this trial is terminated or withdrawn. The trial is conducted by University Hospital, Geneva and has accumulated 11 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 6 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
Jun 2017 — Aug 2017 [monthly]
Terminated NA
-
Jan 2017 — Jun 2017 [monthly]
Terminated NA
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Geneva
- University of Arkansas
- Université de Montréal
For direct contact, visit the study record on ClinicalTrials.gov .